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accomplished with ultraviolet light (λ = 254 nm) and/or the appropriate stain [phosphomolybdic acid, iodine, ninhydrin, and potassium permanganate]. Silica gel chromatography was carried out with SiliaFlash F60
230-400 mesh (Silicycle), according to the method of Still. 6 Mass spectral data were obtained using a
LCMS-IT-TOF mass spectrometer (Shimadzu).
Chemical Synthesis of 1 Compound number in bold refers to the structures shown in Scheme S1.
((2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3-((tert-butyldimethylsilyl)oxy)-4-(4-(4-((4-(4-(hex-5-ynamid o)benzoyl)phenyl)amino)-4-oxobutanamido)butoxy)tetrahydrofuran-2-yl)methyl ((tert-butoxycarbonyl)-L-phenylalanyl)sulfamate (S4a)
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (3.1 mg, 0.016 mmol) and 1-hydroxybenzotriazole (2.5 mg, 0.016 mmol) were added to a solution of compound S8 (6.4 mg, 0.016 mmol) in DMF (1 mL). The solution was stirred at room temperature for 10 min and S3a (10 mg, 0.013 mmol) was then added. After 12 h, the reaction mixture was diluted with EtOAc. The mixture was washed with 5% citric acid, 5% NaHCO 3 , and brine. The organic layer was dried over Na 2 SO 4 and evaporated to dryness. The residue was purified by flash chromatography (6:1 CHCl 3 /MeOH) to afford compound S4a as a white solid (13 mg, 86% 
Chemical Synthesis of 2
Compound number in bold refers to the structures shown in Scheme S1. Boc-Pro-OSu (52 mg, 0.17 mmol) and cesium carbonate (108 mg, 0.33 mmol) were added to a solution of compound S1 (60 mg, 0.11 mmol) in DMF (1 mL). The solution was stirred at room temperature for 1 h. The reaction mixture was then filtered through a pad of Celite. mmol) in DMF (1 mL). The solution was stirred at room temperature for 10 min and S3b (25 mg, 0.034 mmol) was then added. After 18 h, the reaction mixture was diluted with EtOAc. The combined organic layer was washed with 5% citric acid, 5% NaHCO 3 , and brine. 
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Chemical Synthesis of 3
Compound number in bold refers to the structures shown in Scheme S1. 
((2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3-((tert-butyldimethylsilyl)oxy)-4-(4-(4-((4-(4-(hex-5-ynamid o)benzoyl)phenyl)amino)-4-oxobutanamido)butoxy)tetrahydrofuran-2-yl)methyl ((S)-2,5-bis((tert-butoxycarbonyl)amino)pentanoyl)sulfamate (S4c)
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (8.0 mg, 0.043 mmol) and 1-hydroxybenzotriazole (6.6 mg, 0.043 mmol) were added to a solution of compound S8 (17 mg, 0.043 mmol) in DMF (1 mL). The solution was stirred at room temperature for 10 min and S3c (30 mg, 0.035 mmol) was added. After 3 h, the reaction mixture was diluted with EtOAc. The mixture was washed with 5% citric acid, 5% NaHCO 3 , and brine. The organic layer was dried over Na 2 SO 4 and evaporated to dryness. 
Chemical Synthesis of S8
Compound number in bold refers to the structures shown in Scheme S2. in DMF (20 mL). The solution was stirred at room temperature for 5 min and 4, 4′-diaminobenzophenone (500 mg, 2.36 mmol) was added. After 12 h, the reaction mixture was diluted with EtOAc. The mixture was washed with 5% citric acid, 5% NaHCO 3 , and brine. The organic layer was dried over Na 2 SO 4 and evaporated to dryness. The residue was purified by flash chromatography (2:1 EtOAc/hexane) to afford compound S6 as a white solid (410 mg, 53% 
Methyl 4-((4-(4-aminobenzoyl)phenyl)amino)-4-oxobutanoate (S6)
1-Ethyl-3-(3-dimethylaminopropyl)
Methyl 4-((4-(4-(hex-5-ynamido)benzoyl)phenyl)amino)-4-oxobutanoate (S7)
Oxalyl chloride (154 µL, 1.8 mmol) and DMF (20 µL) were added to a solution of 5-hexynoic acid (129 µL, 1.2 mmol) in benzene (10 mL). After 2 h, the flask was placed on the rotary evaporator and the DMF and S21 benzene were removed at reduced pressure to afford 5-hexynoic chloride as a red oil. A solution of crude 5-hexynoyl chloride, compound S6 (185 mg, 0.57 mmol), and DIEA (200 µL, 1.14 mmol) in THF (5 mL) was stirred at room temperature for 9 h. The reaction mixture was diluted with EtOAc. The mixture was washed with 5% citric acid, saturated NaHCO 3 , and brine. 
4-((4-(4-(Hex-5-ynamido)benzoyl)phenyl)amino)-4-oxobutanoic acid (S8)
To 
Chemical Synthesis of 5
Compound number in bold refers to the structures shown in Scheme S3.
5′-O-[N-(N-Boc-L-prolyl)sulfamoyl]-2′,3′-O-isopropylideneadenosine triethylammonium salt (S10a)
Boc-Pro-OSu (63 mg, 0.20 mmol) and cesium carbonate (127 mg, 0.39 mmol) were added to a solution of 5′-O-sulfamoyl-2′,3′-isopropylideneadenosine S9 (50 mg, 0.13 mmol) in DMF (1 mL). The solution was stirred at room temperature for 1 h. The reaction mixture was filtered through a pad of Celite. 
5′-O-[N-(L-Prolyl)sulfamoyl]adenosine triethylammonium salt (5)
Compound S10a (30 mg, 0.044 mmol) was dissolved in 
S23
Chemical Synthesis of 7 Compound number in bold refers to the structures shown in Scheme S3.
5′-O-[N-(N-Boc-L-ornithinyl(δ-Boc))sulfamoyl]-2′,3′-O-isopropylideneadenosine triethylammonium salt (S10b)
Boc-Orn(Boc)-OSu (125 mg, 0.29 mmol) and cesium carbonate (254 mg, 0.78 mmol) were added to a solution of 5′-O-sulfamoyl-2′,3′-isopropylideneadenosine S9 (100 mg, 0.26 mmol) in DMF (3 mL). The solution was stirred at room temperature for 3 h. The reaction mixture was filtered through a pad of Celite.
The filtrate was concentrated under reduced pressure. The residue was purified by flash chromatography 
5′-O-[N-(L-
5′-O-[N-(N-
5′-O-[N-(L-Leucyl)sulfamoyl]adenosine triethylammonium salt (8)
Compound S10c (70 mg, 0.10 mmol) was dissolved in 
Chemical Biology Procedures
Protein Expression and Materials: Recombinant proteins holo-GrsA and holo-TycB1 were expressed and purified as previously described. 2, 7, 8, 9 These proteins were overproduced and isolated as C-terminal His-tagged constructs using the E. coli overexpression strain, BL21 (DE3), kindly provided by Prof. 
Preparation of Lysates for Proteomic Labeling Experiments: Aneurinibacillus migulanus ATCC 9999
was cultured and the whole cell lysate was isolated as described previously. 2 The cellular lysate of A.
migulanus ATCC 9999 has already been used to characterize an affinity probe for adenylation (A) domains in 
Determination of K i app values of inhibitors by the hydroxamate-MesG assay: K i app determination was
performed using standard assay conditions. For holo-GrsA, compound 1 was tested from 25 to 5,000 nM using L-Phe (1 mM) as the competing substrate. The enzyme was fixed at 20 nM. Compounds 2 and 5 were varied from 0.625 to 50 µM, and holo-TycB1 (800 nM) and L-Pro (1 mM) were held constant. In all experiments, the total DMSO concentration was kept at 2.0%. Initial velocities were fit to the Morrison equation using Prism 5 (GraphPad Software).
Labeling of Recombinant GrsA and TycB1 by the Active Site-Directed Proteomic Probes 1 and 2:
Standard conditions for probes 1 and 2-recombinant protein reactions were as follows: recombinant GrsA (1 µM) and TycB1 (1 µM) were treated with probes 1 and 2 (1 µM from a 100 µM stock in DMSO) in assay buffer [20 mM Tris (pH 8.0), 1 mM MgCl 2 , 1 mM TCEP, and 0.0025% Igepal CA-630], respectively. Inhibition studies were performed by pre-incubation of GrsA (1 µM) and TycB1 (1 µM) with L-Phe-AMS 4 and L-Pro-AMS 5 (100 µM from a 10 mM stock in DMSO) for 10 min at room temperature, respectively. In all experiments total DMSO concentration was kept at 2.2%. After 10 min at room temperature, these samples were irradiated at 365 nm for 30 min on ice. To initiate the click reaction, rhodamine (Rh)-azide, TCEP, TBTA ligand, and CuSO 4 were added to provide final concentrations of 100 µM, 1 mM, 100 µM, and 1 mM, respectively. After 1 h at room temperature, 5 SDS-loading buffer (strong reducing) was added and the samples were heated at 95 °C for 5 min. Samples were separated by 1D SDS-PAGE and fluorescent gel visualization was performed using a Typhoon 9410 Gel and Blot Imager (GE Healthcare).
Ultraviolet Photolysis Time Studies:
Recombinant GrsA (1 µM) and TycB1 (1 µM) were treated with probes 1 and 2 (1 µM from a 100 M stock in DMSO; final DMSO concentration of 2.2%) in assay buffer, respectively. After 10 min at room temperature, these samples were irradiated at 365 nm for the indicated time (060 min) on ice, reacted with Rh-azide, and subjected to SDS-PAGE. Fluorescent gel visualization was performed using a Typhoon 9410 Gel and Blot Imager (GE Healthcare).
Limit of Detection of GrsA and TycB1
Labeling: Recombinant GrsA (1500 fmol) and TycB1 (1500 fmol) were treated with probes 1 and 2 (1 µM from a 100 µM stock in DMSO; final DMSO concentration of 2.2%) in assay buffer, respectively. After 10 min at room temperature, these samples were irradiated at 365 nm for S27 30 min on ice and reacted with Rh-azide for 1 h at room temperature. Reactions were treated with 5 SDS-loading buffer (strong reducing) and subjected to SDS-PAGE. Fluorescent gel visualization was performed using a Typhoon 9410 Gel and Blot Imager (GE Healthcare). L-Pro-AMS 5, and L-Val-AMS 6 (100 µM) for 10 min at room temperature, respectively. In all experiments, the total DMSO concentration was kept at 2.2%. After 10 min at room temperature, these samples were irradiated at 365 nm for 30 min on ice, reacted with Rh-azide for 1 h at room temperature, and separated by gel electrophoresis. Fluorescent gel visualization was performed using a Typhoon 9410 Gel and Blot Imager (GE Healthcare).
Comparing the Labeling Property with
GrsA Labeling of A. migulanus ATCC 9999 Proteomes: Aneurinibacillus migulanus proteome (1.4 mg/mL) was treated with probe 1 (1 µM from a 100 µM stock in DMSO) in 20 mM Tris (pH 8.0), 1 mM MgCl 2 , 1 mM TCEP, 0.05% Igepal CA-630, 0.2 mg/mL lysozyme, and protease inhibitor cocktail. Inhibition studies were performed by pre-incubation of A. migulanus proteome (1.4 mg/mL) with L-Phe-AMS 4 (100 µM from a 10 mM stock in DMSO) for 10 min at room temperature. In all experiments, the total DMSO concentration was kept at 2.2%. After 10 min at room temperature, these samples were irradiated at 365 nm for 30 min on ice, reacted with Rh-azide for 1 h at room temperature, and separated by gel electrophoresis.
Fluorescent gel visualization was performed using a Typhoon 9410 Gel and Blot Imager (GE Healthcare).
GrsB Labeling of A. migulanus DSM 5759 Proteomes: Aneurinibacillus migulanus proteome (1.5 mg/mL) was individually treated with probes 2 and 3 (1 µM from a 100 µM stock in DMSO) in 20 mM Tris (pH 8.0), 1 mM MgCl 2 , 1 mM TCEP, 0.05% Igepal CA-630, 0.2 mg/mL lysozyme, and protease inhibitor cocktail. For inhibition studies, A. migulanus proteome (1.5 mg/mL) was individually pre-incubated with L-Pro-AMS 5 and L-Orn-AMS 7 (100 µM from a 10 mM stock in DMSO) for 10 min at room temperature. In all experiments, the total DMSO concentration was kept at 2.2%. After 10 min at room temperature, these samples were irradiated at 365 nm for 5 min and reacted with Rh-azide for 1 h at room temperature. Reactions were treated with 5 SDS-loading buffer (strong reducing) and subjected to SDS-PAGE. Fluorescent gel visualization was performed using a Typhoon 9410 Gel and Blot Imager (GE Healthcare).
Labeling of Individual A Domains and Profiling of A Domain Functions in Native Proteomic
Environments: In order to investigate GrsA labeling, A. migulanus ATCC 9999 proteome (1.5 mg/mL) was individually treated with inhibitors 48 (100 µM from a 10 mM stock in DMSO) in 20 mM Tris (pH 8.0), 1 mM MgCl 2 , 1 mM TCEP, 0.05% Igepal CA-630, 0.2 mg/mL lysozyme, and protease inhibitor cocktail. These samples were incubated for 10 min at room temperature and subsequently treated with probe 1 (1 µM from a 100 µM stock in DMSO). In all experiments, the total DMSO concentration was kept at 2.2%. After 10 min at room temperature, the samples were exposed to ultraviolet light for 30 min on ice and treated with Rh-azide for 1 h at room temperature. To evaluate the labeling of GrsB, the A. migulanus DSM 5759 proteome (1.5 mg/mL) was individually treated with inhibitors 48 (100 µM from a 10 mM stock in DMSO) in 20 mM Tris (pH 8.0), 1 mM MgCl 2 , 1 mM TCEP, 0.05% Igepal CA-630, 0.2 mg/mL lysozyme, and protease inhibitor cocktail. These samples were incubated for 10 min at room temperature and treated with individual members of probes 2 and 3 (1 µM from a 100 µM stock in DMSO). In all reactions, the DMSO concentrations were maintained at a level of 2.2%. After 10 min at room temperature, these samples were irradiated at 365 nm for 5 min on ice and reacted with Rh-azide for 1 h at room temperature. Reactions were treated with 5 SDS-loading buffer (strong reducing) and subjected to SDS-PAGE. Fluorescent gel visualization was performed using a Typhoon 9410 Gel and Blot Imager (GE Healthcare).
Mass Spectroscopic Analysis, 1D SDS-PAGE, and In-gel Digestion:
The proteins were separated by 1D SDS-PAGE by using 6% wide range gels (Nacalai tesque) and visualized using Sil-best stain one (Nacalai tesque). The bands were excised, destained using destaining solution in the Silver Stain MS Kit (Wako Pure Chemical Industries, Ltd), and subjected to in-gel digestion with TPCK-treated trypsin in the digestion buffer (10 mM Tris-HCl, pH 8.0 and 0.05% decyl glucoside) for 12 h at 37 °C. 1 H-NMR (500 MHz) and 13 C-NMR (125 MHz) spectra of S10b in CD 3 
